IN3BIO   Report issue

For profit Phase 1
Founded: Aberdeen United Kingdom (2010)

Organization Overview

First Clinical Trial
2020
NCT04537130
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

IN3BIO

Active Ingredients

Drugs in Phase 1 Trials (1)

in01 vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 1)

Pulmonary Fibrosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1